The U.S. Department of Health and Human Services (HHS) is re-evaluating its stance on fluoride in drinking water by reconvening the Community Preventive Services Task Force, an independent panel of health experts. This move follows Health Secretary Robert F. Kennedy Jr.’s recent statement in Salt Lake City, indicating plans to halt the Centers for Disease Control and Prevention’s recommendation for community water fluoridation.
Fluoride, commonly added to public water supplies to prevent tooth decay, has been a controversial topic for decades. While the American Dental Association continues to support fluoridation as an effective dental health measure, concerns about potential health risks have gained traction.
The Environmental Protection Agency (EPA) will also review new scientific data on fluoride’s health effects. EPA Administrator Lee Zeldin confirmed that this effort is in collaboration with HHS, with the goal of re-evaluating the agency’s current enforceable fluoride limit of 4.0 milligrams per liter (mg/L). Currently, the U.S. Public Health Service recommends maintaining levels below 0.7 mg/L. Studies show that exposure above 1.5 mg/L can increase risks of bone fractures, thyroid dysfunction, and neurological damage.
In a landmark move, Utah became the first state to ban fluoride in public water systems after Governor Spencer Cox signed new legislation last month. The decision faced strong opposition from health experts and organizations, including the American Dental Association.
As of 2022, about 63% of Americans receive fluoridated water through their municipal systems. A 2024 federal court ruling ordered the EPA to tighten its standards, citing unacceptable health risks to children under current fluoride levels. While Kennedy claims links between fluoride and conditions like cancer, his statements remain unsubstantiated by definitive scientific evidence.


Newly Released DOJ Epstein Files Expose High-Profile Connections Across Politics and Business
South Korea Assures U.S. on Trade Deal Commitments Amid Tariff Concerns
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Iran–U.S. Nuclear Talks in Oman Face Major Hurdles Amid Rising Regional Tensions
Ukraine-Russia Talks Yield Major POW Swap as U.S. Pushes for Path to Peace
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Trump Allows Commercial Fishing in Protected New England Waters
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate
Nighttime Shelling Causes Serious Damage in Russia’s Belgorod Region Near Ukraine Border
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
U.S. and Rwanda Sign $228 Million Health Partnership to Boost Self-Reliance
NATO to Discuss Strengthening Greenland Security Amid Arctic Tensions 



